Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The operating income for Alpha Tau Medical Ltd. as of June 30, 2025 is -37.52 MM.
- The net income for Alpha Tau Medical Ltd. as of June 30, 2025 is -35.20 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -37.52 | -35.20 | |
2025-03-31 | -36.93 | -32.46 | |
2024-12-31 | -36.04 | -31.75 | |
2024-09-30 | -35.71 | -29.64 | |
2024-06-30 | -36.35 | -27.63 | |
2024-03-31 | -35.46 | -28.95 | |
2023-12-31 | -35.68 | -29.16 | |
2023-09-30 | -33.72 | -25.19 | |
2023-06-30 | -32.16 | -22.90 | |
2023-03-31 | -32.00 | -16.20 | |
2022-12-31 | -32.14 | -33.76 | |
2022-09-30 | -28.09 | -34.15 | |
2022-06-30 | -24.37 | -36.32 | |
2022-03-31 | -19.84 | -41.30 | |
2021-12-31 | -13.79 | -27.27 | |
2021-09-30 | -12.56 | -25.91 | |
2021-06-30 | -11.64 | -23.54 | |
2021-03-31 | -10.07 | -18.57 | |
2020-12-31 | -9.24 | -8.88 |
Income Statement: EPS
- The earnings per share basic for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.48.
- The earnings per share diluted for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.48.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | -0.48 | -0.48 |
2025-03-31 | -0.46 | -0.46 |
2024-12-31 | -0.45 | |
2024-09-30 | -0.42 | -0.42 |
2024-06-30 | -0.40 | -0.40 |
2024-03-31 | -0.42 | -0.42 |
2023-12-31 | -0.42 | |
2023-09-30 | -0.36 | -0.36 |
2023-06-30 | -0.33 | -0.33 |
2023-03-31 | -0.23 | -0.23 |
2022-12-31 | -0.53 | |
2022-09-30 | -0.61 | -0.61 |
2022-06-30 | -0.74 | -0.74 |
2022-03-31 | -0.98 | -0.98 |
2021-12-31 | -0.67 | |
2021-09-30 | -0.65 | -0.65 |
2021-06-30 | -0.60 | -0.60 |
2021-03-31 | -0.47 | -0.47 |
2020-12-31 | -0.22 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Alpha Tau Medical Ltd. as of June 30, 2025 is -21.59 MM.
- The cash from investing activities for Alpha Tau Medical Ltd. as of June 30, 2025 is -6.29 MM.
- The cash from financing activities for Alpha Tau Medical Ltd. as of June 30, 2025 is 36.76 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -21.59 | -6.29 | 36.76 |
2025-03-31 | |||
2024-12-31 | -19.78 | 20.77 | 0.03 |
2024-09-30 | |||
2024-06-30 | -20.84 | 16.57 | 5.32 |
2024-03-31 | |||
2023-12-31 | -17.96 | 18.68 | 5.30 |
2023-09-30 | |||
2023-06-30 | -18.47 | 7.71 | 0.11 |
2023-03-31 | |||
2022-12-31 | -23.88 | -89.94 | 96.91 |
2022-09-30 | |||
2022-06-30 | -21.77 | -74.69 | 96.89 |
2022-03-31 | -15.27 | 19.58 | 82.09 |
2021-12-31 | -11.81 | 19.27 | 0.11 |
2021-09-30 | |||
2021-06-30 | -9.18 | 4.81 | 4.92 |
2021-03-31 | -8.66 | -2.76 | 17.11 |
2020-12-31 | -7.25 | -7.82 | 29.32 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Alpha Tau Medical Ltd. as of June 30, 2025 is -6.76.
- The p/book for Alpha Tau Medical Ltd. as of June 30, 2025 is 3.89.
- The p/tbv for Alpha Tau Medical Ltd. as of June 30, 2025 is 3.89.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -6.76 | 3.89 | 3.89 |
2025-03-31 | -5.63 | 2.85 | 2.85 |
2024-12-31 | 3.12 | 3.12 | |
2024-09-30 | -5.90 | 2.20 | 2.20 |
2024-06-30 | -6.03 | 2.21 | 2.21 |
2024-03-31 | 2.43 | 2.43 | |
2023-12-31 | -8.27 | 2.32 | 2.32 |
2023-09-30 | -10.27 | 2.54 | 2.54 |
2023-06-30 | -8.12 | 2.59 | 2.59 |
2023-03-31 | -5.88 | 1.88 | 1.88 |
2022-12-31 | 2.05 | 2.05 | |
2022-09-30 | 3.72 | 3.72 | |
2022-06-30 | -14.38 | 6.32 | 6.32 |
2022-03-31 | -42.15 | 30.40 | 30.40 |
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.15.
- The ebit (3y)/ev for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.13.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.15 | -0.13 |
2025-03-31 | -0.19 | -0.15 |
2024-12-31 | -0.14 | -0.14 |
2024-09-30 | -0.17 | -0.18 |
2024-06-30 | -0.17 | -0.17 |
2024-03-31 | -0.15 | -0.11 |
2023-12-31 | -0.12 | -0.14 |
2023-09-30 | -0.10 | -0.12 |
2023-06-30 | -0.13 | -0.12 |
2023-03-31 | -0.18 | -0.16 |
2022-12-31 | -0.16 | -0.09 |
2022-09-30 | -0.09 | -0.05 |
2022-06-30 | -0.07 | -0.04 |
2022-03-31 | -0.02 | -0.01 |
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Management Effectiveness
- The roa for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.34.
- The roe for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.44.
- The roic for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.47.
- The croic for Alpha Tau Medical Ltd. as of June 30, 2025 is 0.02.
- The ocroic for Alpha Tau Medical Ltd. as of June 30, 2025 is -0.29.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2025-06-30 | -0.34 | -0.44 | -0.47 | 0.02 | -0.29 |
2025-03-31 | -0.31 | -0.40 | -0.42 | 0.01 | -0.26 |
2024-12-31 | -0.28 | -0.35 | -0.36 | 0.01 | -0.25 |
2024-09-30 | -0.26 | -0.31 | -0.32 | 0.01 | -0.24 |
2024-06-30 | -0.25 | -0.29 | -0.31 | 0.06 | -0.20 |
2024-03-31 | -0.24 | -0.28 | -0.30 | 0.06 | -0.18 |
2023-12-31 | -0.21 | -0.23 | -0.26 | -0.11 | -0.19 |
2023-09-30 | -0.18 | -0.21 | -0.23 | -0.11 | -0.19 |
2023-06-30 | -0.27 | -0.31 | -0.23 | -0.11 | -0.19 |
2023-03-31 | -0.28 | -0.36 | -0.15 | -0.16 | -0.23 |
2022-12-31 | -0.73 | -0.76 | -0.32 | 0.00 | 0.00 |
2022-09-30 | -0.86 | -0.96 | -0.32 | 0.01 | -0.20 |
2022-06-30 | -0.88 | -0.92 | -0.34 | 0.01 | -0.20 |
2022-03-31 | -0.58 | -0.61 | -0.44 | 0.93 | -0.16 |
2021-12-31 | -0.51 | -0.54 | -0.72 | 0.20 | -0.31 |
2021-09-30 | -0.48 | -0.50 | -0.69 | 0.10 | -0.28 |
2021-06-30 | -0.53 | 0.00 | -0.21 | ||
2021-03-31 | -0.61 | -0.36 | 0.10 | -0.18 | |
2020-12-31 | -0.28 | -0.29 | -0.17 | 0.28 | -0.14 |
Gross Margins
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Identifiers and Descriptors
Central Index Key (CIK) |